We are live on ! Find out more
GLSI icon

Greenwich LifeSciences

39 hedge funds and large institutions have $16.4M invested in Greenwich LifeSciences in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

15% more funds holding

Funds holding: 3439 (+5)

0.75% more ownership

Funds ownership: 7.93%8.67% (+0.75%)

7% less capital invested

Capital invested by funds: $17.6M → $16.4M (-$1.23M)

Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
13
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GLSI Hedge Fund Activity: Q3 2024 in Review

39 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2024, worth a combined $16.4M — down 7% from $17.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new GLSI positions and 3 closed out — a net gain of 5 holders — while 13 added to existing stakes and 8 trimmed.

The largest buyer was Northern Trust, adding an estimated $744K. The largest seller was Man Group, exiting entirely with an estimated $287K sold.

  • 39 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2024, up from 34 in Q2 2024.
  • Funds reported $16.4M of Greenwich LifeSciences stock for Q3 2024, down 7% quarter-over-quarter.
  • 8 funds opened new Greenwich LifeSciences positions in Q3 2024 and 3 closed out, a net change of +5 holders.
  • The largest Greenwich LifeSciences buyer in Q3 2024 was Northern Trust, an estimated $744K added.
  • The largest Greenwich LifeSciences seller in Q3 2024 was Man Group, an estimated $287K sold.

Based on aggregated 13F filings for Q3 2024.